-
Targeted gene-altering therapy reduced LDL-cholesterol levels by 50 per cent in patients with severely elevated cholesterol levels.
Medical Mythbusting Commentary for September 2, 2026 Source:With the snip of a gene, scientists hope to erase high cholesterol for life Reference:Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3
-
Phase 1 targeted gene editing study demonstrates safety and reduction in LDL cholesterol levels through specific protein pathway
Medical Mythbusting Commentary for August 17, 2026 Source:‘An extremely exciting milestone!’: landmark treatment slashes cholesterol by 62% with a single dose Reference:In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia
-
B.C. man cured of rare disease in world-first for new gene-editing technology
Medical Mythbusting Commentary for February 27, 2026 Source:B.C. man cured of rare disease in world-first for new gene-editing technology Reference:Prime Editing for p47phox-Deficient Chronic Granulomatous Disease
-
Epigenetic Switch to Turn Memories On and Off Created in Mice.
Medical Mythbusting Commentary for November 14, 2025 Source:Epigenetic Switch to Turn Memories On and Off Created Reference:Cell-type and locus-specific epigenetic editing of memory expression
-
Huntington’s disease: Neurological illness treated in ‘one shot,’ researcher says. Slows progression up to 75% in phase I/II trial
Medical Mythbusting Commentary for September 29, 2025 Source:Huntington’s disease: Neurological illness treated in ‘one shot,’ researcher says
-
Pig kidney transplants take a step forward with approval of human trials
Medical Mythbusting Commentary for September 12, 2025 Source:Pig kidney transplants take a step forward with approval of human trials
-
Pioneering gene therapy restores UK girl’s hearing. A truly wonderful outcome.
Medical Mythbusting Commentary for May 23, 2024 Source:Pioneering gene therapy restores UK girl’s hearing
-
Gene therapies that let deaf children hear bring hope—and many questions
Medical Mythbusting Commentary for February 1, 2024 Source:Gene therapies that let deaf children hear bring hope—and many questions
-
The First Crispr Medicine Is Now Approved in the US to Treat Sickle Cell Anemia
Medical Mythbusting Commentary for December 11, 2023 Source:The First Crispr Medicine Is Now Approved in the US